Viking Therapeutics, Inc. (VKTX)

NASDAQ: VKTX · Real-Time Price · USD

32.83

-0.92 (-2.73%)

Oct 21, 2025, 3:33 PM EDT - Market open

Viking Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Oct '25 Oct 21, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	3,692	4,484	1,862	721	360	411	Upgrade
Market Cap Growth	-47.64%	140.89%	158.23%	100.31%	-12.38%	-29.13%	Upgrade
Enterprise Value	2,957	3,555	1,487	567	144	156	Upgrade
Last Close Price	33.75	40.24	18.61	9.40	4.60	5.63	Upgrade
PB Ratio	4.77	5.09	5.34	4.96	1.78	1.68	Upgrade
P/TBV Ratio	4.73	5.09	5.34	4.96	1.78	1.68	Upgrade
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0	0.00	Upgrade
Quick Ratio	25.26	32.93	18.92	7.09	23.02	20.48	Upgrade
Current Ratio	25.86	33.09	19.19	7.61	23.98	21.12	Upgrade
Return on Equity (ROE)	-19.99%	-17.90%	-34.79%	-39.67%	-24.65%	-15.15%	Upgrade
Return on Assets (ROA)	-14.99%	-14.77%	-23.47%	-23.19%	-14.90%	-9.86%	Upgrade
Return on Capital (ROIC)	-15.48%	-15.32%	-25.38%	-25.21%	-15.58%	-10.21%	Upgrade
Earnings Yield	-4.56%	-2.45%	-4.61%	-9.55%	-15.28%	-9.62%	Upgrade
Buyback Yield / Dilution	-7.91%	-15.57%	-22.79%	0.47%	-6.34%	-0.89%	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q